Indian Mycophenolate Exporters: Complete Supplier Ranking with Market Share — 167 Manufacturers (2026) — TransData Nexus

Q: Who is the largest mycophenolate supplier from India?

INTAS PHARMACEUTICALS LIMITED is the largest mycophenolate exporter from India with a 61.7% market share and export value of $206.5M.

Q: How many mycophenolate suppliers are there in India?

There are 167 active mycophenolate exporters in India, collectively shipping $334.4M worth of mycophenolate across 2,529 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top mycophenolate suppliers from India?

The top 5 mycophenolate suppliers from India — INTAS PHARMACEUTICALS LIMITED, STRIDES PHARMA SCIENCE LIMITED, ALKEM LABORATORIES LIMITED, SANDOZ PRIVATE LIMITED, EMCURE PHARMACEUTICALS LIMITED — together control 93.1% of total mycophenolate export value from India.

Suresh Sormare

Mycophenolate

India Pharmaceutical Trade Intelligence

$334.4M167 Suppliers100 CountriesHS 30049099

ExportsIndia → UNITED STATES76.6%India → AUSTRALIA6.1%

ImportsGERMANY → India$999.6M ITALY → India$223.6M

#1 Supplier: INTAS PHARMACEUTICALS #1 Buyer: EVERSANA LIFE

Mycophenolate Suppliers from India (2026) — 167 Exporters, $334.4M Market | TransData Nexus | TransData Nexus

Who Exports Mycophenolate from India — 167 Suppliers Behind a $334.4M Market

India's mycophenolate export market is supplied by 167 active exporters who collectively shipped $334.4M across 2,529 shipments. INTAS PHARMACEUTICALS LIMITED leads with a 61.7% market share, followed by STRIDES PHARMA SCIENCE LIMITED and ALKEM LABORATORIES LIMITED. The top 5 suppliers together control 93.1% of total export value, reflecting a concentrated market structure.

Source: Indian Customs (DGFT)·Published May 2026

India's Top Mycophenolate Suppliers & Exporters — 167 manufacturers, $334.4M export market, top destinations and formulations — Mycophenolate supplier data — 167 exporters · $334.4M market · 2,529 shipmentsTransData Nexus · Indian Customs Data

Top Mycophenolate Exporters from India — Ranked by Export Value

INTAS PHARMACEUTICALS LIMITED is the leading mycophenolate exporter from India, holding a 61.7% share of the $334.4M market across 2,529 shipments from 167 exporters. The top 5 suppliers — INTAS PHARMACEUTICALS LIMITED, STRIDES PHARMA SCIENCE LIMITED, ALKEM LABORATORIES LIMITED, SANDOZ PRIVATE LIMITED, EMCURE PHARMACEUTICALS LIMITED — collectively control 93.1% of total export value, indicating a highly concentrated market. Individual shares are: INTAS PHARMACEUTICALS LIMITED (61.7%), STRIDES PHARMA SCIENCE LIMITED (10.5%), ALKEM LABORATORIES LIMITED (8.8%), SANDOZ PRIVATE LIMITED (7.9%), EMCURE PHARMACEUTICALS LIMITED (4.2%).

Top Mycophenolate Exporters from India

Ranked by export value · 167 active suppliers · Indian Customs (DGFT) data

May 2026

Top Mycophenolate Exporters from India — Ranked by Export Value. 167 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1

Mycophenolate — Export Intelligence Video

Visual overview of India's mycophenolate supplier landscape — top suppliers, destinations, pricing, and trade routes

This video covers India's mycophenolate pharmaceutical supplier landscape — $334.4M in total trade, 167 verified manufacturers. Data sourced from Indian Customs (DGFT) shipment records.

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Mycophenolate exporters

Certification and compliance status for top Mycophenolate suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
Intas Pharmaceuticals Limited	Approved	Yes (April 2007)	Yes	Multiple	FDA approval for multiple drugs; WHO-GMP certified in April 2007; EU GMP complia
Strides Pharma Science Limited	Approved	Unknown	Unknown	Multiple	FDA approval for multiple drugs; no FDA warning letters found.
Alkem Laboratories Limited	Approved	Unknown	Unknown	Multiple	FDA approval for multiple drugs; no FDA warning letters found.
Emcure Pharmaceuticals Limited	Approved	Unknown	Unknown	Multiple	FDA approval for multiple drugs; no FDA warning letters found.
Panacea Biotec Pharma Limited	Unknown	Yes (June 2023)	Unknown	Unknown	WHO-GMP certified in June 2023; no FDA warning letters found.
Mylan Laboratories Limited	Approved	Unknown	Unknown	Multiple	FDA approval for multiple drugs; no FDA warning letters found.
Concord Biotech Limited	Approved	Unknown	Unknown	Multiple	FDA approval for multiple drugs; no FDA warning letters found.
Sandoz Private Limited	Approved	Unknown	Unknown	Multiple	FDA approval for multiple drugs; no FDA warning letters found.

TransData Nexus reviewed the regulatory standing of 8 leading Mycophenolate exporters from India. 7 hold US FDA facility approvals, 2 maintain WHO-GMP certification, and 1 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Mycophenolate sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Bulk Drug Capital of India," contributes over 40% of the country's bulk drug production. The city hosts more than 2,000 pharmaceutical companies, including major players like Dr. Reddy's Laboratories and Aurobindo Pharma. The establishment of Hyderabad Pharma City, recognized as a National Investment Manufacturing Zone in December 2019, further solidifies its position as a pharmaceutical hub.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its pharmaceutical formulations and biogenerics manufacturing. Vadodara, in particular, is home to numerous pharmaceutical companies, contributing significantly to the state's pharmaceutical output. The region's focus on formulations makes it a strategic location for companies involved in the production of finished dosage forms.

3Mumbai-Thane-Raigad — Export Gateway

The Mumbai-Thane-Raigad belt serves as a crucial export gateway for India's pharmaceutical industry. Mumbai, being a major port city, facilitates the export of pharmaceutical products to global markets. The region's well-established infrastructure and proximity to international shipping routes make it an ideal location for companies aiming to expand their global footprint.

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Mycophenolate exporters from India

October 2016

M&A

Intas Pharmaceuticals Limited — Intas acquires Teva's UK & Ireland assets for $764 million

In October 2016, Intas Pharmaceuticals Limited acquired the UK and Ireland assets of Teva Pharmaceuticals for $764 million. This strategic acquisition expanded Intas's presence in the European market, enhancing its portfolio and manufacturing capabilities. IMPACT: The acquisition bolstered Intas's production capacity, potentially increasing Mycophenolate exports to European markets.

Impact: The acquisition bolstered Intas's production capacity, potentially increasing Mycophenolate exports to European markets.

March 2021

Capacity Expansion

Intas Pharmaceuticals Limited — Intas sets up new manufacturing facility in PHARMEZ

In March 2021, Intas Pharmaceuticals Limited established a new manufacturing facility in PHARMEZ (Bavla, near Ahmedabad) with the capacity to manufacture and export over 1 billion solid dosages and 5 million injectables. This expansion aimed to meet growing global demand. IMPACT: The increased production capacity may lead to higher Mycophenolate export volumes.

Impact: The increased production capacity may lead to higher Mycophenolate export volumes.

Common Questions — Mycophenolate Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which mycophenolate supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, INTAS PHARMACEUTICALS LIMITED leads with 454 recorded shipments worth $206.5M. STRIDES PHARMA SCIENCE LIMITED (193 shipments) and ALKEM LABORATORIES LIMITED (356 shipments) are also established high-volume exporters.

Q How many mycophenolate manufacturers are there in India?

India has 167 active mycophenolate exporters with a combined export market of $334.4M across 2,529 shipments to 100 countries. The top 5 suppliers hold 93.1% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for mycophenolate from India?

Average FOB unit price: $15.03 per unit, ranging from $0.00 to $400.57. Average shipment value: .

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Mycophenolate

Mycophenolate

Who Exports Mycophenolate from India — 167 Suppliers Behind a $334.4M Market

Top Mycophenolate Exporters from India — Ranked by Export Value

Top Mycophenolate Exporters from India

Related Analysis

Need Details?

Mycophenolate — Export Intelligence Video

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Intas Pharmaceuticals Limited — Intas acquires Teva's UK & Ireland assets for $764 million

Intas Pharmaceuticals Limited — Intas sets up new manufacturing facility in PHARMEZ

Common Questions — Mycophenolate Suppliers from India

Q Which mycophenolate supplier from India is the most reliable for bulk orders?

Q How many mycophenolate manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for mycophenolate from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Intas Pharmaceuticals Limited — Intas acquires Sanofi's Fawdon manufacturing site

Analysis Methodology